{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:54:06Z","timestamp":1791201246467,"version":"4.2.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary hypertension (PH) is a common comorbidity of interstitial lung disease (ILD). Timely detection may improve outcomes through implementation of PH specific treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective, multicenter study aiming to identify features that predict PH in patients with ILD. In the derivation cohort (ILD cohort\u2014University of South Florida), we identified predictors of PH in ILD and created a scoring system using the rounded value of odds ratio for each significant parameter. Correlation with hemodynamic parameters was investigated in the derivation and validation cohort (Idiopathic Pulmonary Fibrosis cohort\u2014Cleveland Clinic).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 164 patients with ILD that underwent right heart catheterization (RHC) [derivation cohort:\n                      <jats:italic>n<\/jats:italic>\n                      = 118, median age (years, 95% CI): 69.0 (65.9\u201371.0), female gender: 65 (54.6%), median mean pulmonary arterial pressure (mPAP) (mmHg, 95% CI): 25.0 (23.0\u201327.0), median pulmonary vascular resistance (PVR) [Wood units (WU), 95% CI]: 3.6 (3.0\u20134.3), validation cohort:\n                      <jats:italic>n<\/jats:italic>\n                      = 46, median age (95% CI): 63.0 (60.0\u201366.0), female gender: 17 (37%), median mPAP (mmHg, 95% CI): 20.5 (18.0\u201327.2), median PVR (WU, 95% CI): 3.1 (2.2\u20133.4)]. Parameters and optimal cut-offs that significantly predicted precapillary PH in the derivation cohort were: age&amp;gt;42 years, heart rate recovery (HRR) at 1 min \u2264 15 bpm in 6-min walk test (6 MWT), 6-min walk distance (6 MWD) \u2264 270 meters, B-type natriuretic peptide (BNP) &amp;gt; 136 pg\/mL, pulmonary artery to ascending aorta diameter ratio (PA\/AA) &amp;gt; 1 in high-resolution computed tomography (HRCT), main PA diameter &amp;gt; 29 mm in HRCT, right ventricular systolic pressure &amp;gt; 42 mmHg on echocardiogram. We created a PH detection model that ranged from 0 to 28. The optimal cut-off threshold for the detection of PH was &amp;gt; 14 (80% sensitivity, 68% specificity, AUC: 0.78). A simplified scoring system without BNP and main PA diameter (range: 0\u201321) maintained the same AUC. The simplified scoring system exhibited positive correlation with mean pulmonary artery pressure both in the derivation (rho = 0.47,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.0001) and validation cohort (rho = 0.36,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that incorporation of demographic, functional, imaging, and echocardiographic characteristics can optimize the early identification of precapillary PH in patients with ILD, paving the way to structured screening strategies. Timely detection of PH might lead to timely implementation of emerging PH specific treatments in patients with ILDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1908302","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:10:27Z","timestamp":1791198627000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary hypertension optimal screening in interstitial lung disease (PHOS-ILD): a scoring system for the detection of pulmonary hypertension in patients with interstitial lung disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Theodoros","family":"Karampitsakos","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]},{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Stagaki","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Thottassery","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorden","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda","family":"Asif","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Soto","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Arce Guzman","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalen","family":"Hammonds","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Papasarantou","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agamemnon","family":"Bakakos","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Papaioannou","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Matsioulas","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foteini","family":"Karakontaki","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Loverdos","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Kefalidou","sequence":"additional","affiliation":[{"name":"First Department of Pulmonary, Critical Care and Sleep Medicine, Hospital for Thoracic Diseases \u201cSOTIRIA,\u201d National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Juan-Guardela","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose D.","family":"Herazo-Maya","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano R.","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Integrated Hospital Care Institute, Cleveland Clinic","place":["Cleveland, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Bandyopadhyay","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Ubben Center for Pulmonary Fibrosis Research, Morsani College of Medicine, University of South Florida","place":["Tampa, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2500158","DOI":"10.1183\/13993003.00158-2025","article-title":"Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS\/ATS statement.","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur Respir J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104766","DOI":"10.1016\/j.ebiom.2023.104766","article-title":"Precision medicine advances in idiopathic pulmonary fibrosis.","volume":"95","author":"Karampitsakos","year":"2023","journal-title":"EBioMedicine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/resp.14363","article-title":"Lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective multicentre study in Europe.","volume":"28","author":"Karampitsakos","year":"2023","journal-title":"Respirology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1306032","DOI":"10.3389\/fmed.2023.1306032","article-title":"Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future.","volume":"10","author":"Arslan","year":"2023","journal-title":"Front Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1164\/rccm.202502-0465ED","article-title":"A twist in the fibrotic tale: the overlooked vasculopathy in idiopathic pulmonary fibrosis.","volume":"211","author":"Tonelli","year":"2025","journal-title":"Am J Respir Crit Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/diagnostics13142354","article-title":"Pulmonary hypertension in the course of interstitial lung diseases-a personalised approach is needed to identify a dominant cause and provide an effective therapy.","volume":"13","author":"Kacprzak","year":"2023","journal-title":"Diagnostics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4081\/monaldi.2021.2027","article-title":"Spectrum of interstitial lung diseases and their association with pulmonary hypertension.","volume":"92","author":"Tyagi","year":"2021","journal-title":"Monaldi Arch Chest Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pupt.2018.03.002","article-title":"Pulmonary hypertension in patients with interstitial lung disease.","volume":"50","author":"Karampitsakos","year":"2018","journal-title":"Pulm Pharmacol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1183\/09031936.00010414","article-title":"A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis.","volume":"44","author":"Oliveira","year":"2014","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/ajrccm\/aamag055","article-title":"Pre-lung transplant monocyte counts are associated with post-lung transplant survival in idiopathic pulmonary fibrosis.","volume":"212","author":"Karampitsakos","year":"2026","journal-title":"Am J Respir Crit Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1183\/13993003.01537-2014","article-title":"Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur Respir J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12931-018-0845-5","article-title":"The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.","volume":"19","author":"Guenther","year":"2018","journal-title":"Respir Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2045894021999960","DOI":"10.1177\/2045894021999960","article-title":"Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database.","volume":"11","author":"Nathan","year":"2021","journal-title":"Pulm Circ."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.chest.2024.10.042","article-title":"The Dawn of Precision Medicine in Fibrotic Interstitial Lung Disease.","volume":"167","author":"Karampitsakos","year":"2025","journal-title":"Chest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2401200","DOI":"10.1183\/13993003.01200-2024","article-title":"Pulmonary hypertension associated with lung diseases.","volume":"64","author":"Shlobin","year":"2024","journal-title":"Eur Respir J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension.","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur Respir J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1183\/23120541.00272-2022","article-title":"Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need.","volume":"8","author":"Dhont","year":"2022","journal-title":"ERJ Open Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/life14091203","article-title":"Converging pathways: a review of pulmonary hypertension in interstitial lung disease.","volume":"14","author":"Lawrence","year":"2024","journal-title":"Life."},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccm.2013.08.004","article-title":"Pulmonary hypertension due to lung disease and\/or hypoxia.","volume":"34","author":"Nathan","year":"2013","journal-title":"Clin Chest Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000114246","article-title":"Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.","volume":"76","author":"Nathan","year":"2008","journal-title":"Respiration."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12127","DOI":"10.1002\/pul2.12127","article-title":"Clinical significance of pulmonary hypertension in interstitial lung disease: a consensus statement from the Pulmonary Vascular Research Institute\u2019s innovative drug development initiative-Group 3 pulmonary hypertension.","volume":"12","author":"Nikkho","year":"2022","journal-title":"Pulm Circ."},{"key":"B24","doi-asserted-by":"publisher","first-page":"OA5000","DOI":"10.1183\/13993003.congress-2015.OA5000","article-title":"Pulmonary hypertension due to lung disease \u2013 Results from COMPERA.","volume":"46","author":"Gr\u00fcnig","year":"2015","journal-title":"Eur Respir J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.chest.2025.07.4107","article-title":"Pulmonary Hypertension Associated With Interstitial Lung Diseases.","volume":"169","author":"Jose","year":"2025","journal-title":"Chest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/life13051202","article-title":"Should we change the target of therapy in pulmonary hypertension?","volume":"13","author":"Karyofyllis","year":"2023","journal-title":"Life."},{"key":"B27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/CEOR.S119117","article-title":"Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes.","volume":"9","author":"Burger","year":"2017","journal-title":"Clin Outcomes Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease.","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa2512911","article-title":"Inhaled treprostinil for idiopathic pulmonary fibrosis.","volume":"395","author":"Nathan","year":"2026","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa2501488","article-title":"Phase 3 trials of inhaled treprostinil for idiopathic pulmonary fibrosis.","volume":"395","author":"Nathan","year":"2026","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1002\/pul2.70005","article-title":"Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): a consensus statement from the pulmonary vascular research institute\u2019s innovative drug development initiative-group 3 pulmonary hypertension.","volume":"14","author":"Vitulo","year":"2024","journal-title":"Pulm Circ."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline.","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","article-title":"Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a multidisciplinary delphi study.","volume":"162","author":"Rahaghi","year":"2022","journal-title":"Chest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.healun.2023.11.005","article-title":"Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: evolution of the model FORD.","volume":"43","author":"Nathan","year":"2024","journal-title":"J Heart Lung Transplant."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12141","DOI":"10.1002\/pul2.12141","article-title":"Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.","volume":"12","author":"Parikh","year":"2022","journal-title":"Pulm Circ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e12273","DOI":"10.1002\/pul2.12273","article-title":"The PH-ILD Detection tool: external validation and use in patients with ILD.","volume":"13","author":"Parikh","year":"2023","journal-title":"Pulm Circ."},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00408-024-00783-2","article-title":"Performance of the FORD versus other available models for the noninvasive prediction of pulmonary hypertension in patients with interstitial lung disease.","volume":"203","author":"Kim","year":"2025","journal-title":"Lung."},{"key":"B41","doi-asserted-by":"publisher","first-page":"240092","DOI":"10.1183\/16000617.0092-2024","article-title":"Noninvasive diagnostic modalities and prediction models for detecting pulmonary hypertension associated with interstitial lung disease: a narrative review.","volume":"33","author":"Arvanitaki","year":"2024","journal-title":"Eur Respir Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.11909\/j.issn.1671-5411.2017.01.001","article-title":"Epidemiology of pulmonary hypertension in the elderly.","volume":"14","author":"\u00d6rem","year":"2017","journal-title":"J Geriatr Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1161\/CIRCRESAHA.121.319815","article-title":"Endothelial senescence: a new age in pulmonary hypertension.","volume":"130","author":"Culley","year":"2022","journal-title":"Circ Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e000137","DOI":"10.1136\/bmjmed-2022-000137","article-title":"Pathophysiology and new advances in pulmonary hypertension.","volume":"2","author":"Bousseau","year":"2023","journal-title":"BMJ Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1440-1843.2010.01877.x","article-title":"Heart rate recovery after six-minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis.","volume":"16","author":"Swigris","year":"2011","journal-title":"Respirology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e12197","DOI":"10.1002\/pul2.12197","article-title":"Noninvasive determinants of pulmonary hypertension in interstitial lung disease.","volume":"13","author":"Joseph","year":"2023","journal-title":"Pulm Circ."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0268839","DOI":"10.1371\/journal.pone.0268839","article-title":"Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension.","volume":"17","author":"Rezende","year":"2022","journal-title":"PLoS One."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1183\/09031936.00131813","article-title":"6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis.","volume":"43","author":"du Bois","year":"2014","journal-title":"Eur Respir J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"220087","DOI":"10.1183\/16000617.0087-2022","article-title":"The 6-min walk test as a primary end-point in interstitial lung disease.","volume":"31","author":"Harari","year":"2022","journal-title":"Eur Respir Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"210220","DOI":"10.1183\/16000617.0220-2021","article-title":"Recent advances in the management of pulmonary hypertension with interstitial lung disease.","volume":"31","author":"Waxman","year":"2022","journal-title":"Eur Respir Rev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCIMAGING.111.968610","article-title":"Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study.","volume":"5","author":"Truong","year":"2012","journal-title":"Circ Cardiovasc Imaging."},{"key":"B52","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1183\/23120541.00232-2019","article-title":"Performance of pulmonary artery dimensions measured on high-resolution computed tomography scan for identifying pulmonary hypertension.","volume":"6","author":"Ratanawatkul","year":"2020","journal-title":"ERJ Open Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.rmed.2008.03.022","article-title":"Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.","volume":"102","author":"Nathan","year":"2008","journal-title":"Respir Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1001\/jamacardio.2019.3345","article-title":"Association of mild echocardiographic pulmonary hypertension with mortality and right ventricular function.","volume":"4","author":"Huston","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e033084","DOI":"10.1136\/bmjopen-2019-033084","article-title":"Diagnostic accuracy of transthoracic echocardiography for pulmonary hypertension: a systematic review and meta-analysis.","volume":"9","author":"Ni","year":"2019","journal-title":"BMJ Open."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2200481","DOI":"10.1183\/13993003.00481-2022","article-title":"Unbowed, unbent, unbroken: predicting pulmonary hypertension using echocardiography.","volume":"60","author":"van de Veerdonk","year":"2022","journal-title":"Eur Respir J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.rmed.2014.12.011","article-title":"Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model.","volume":"109","author":"Ruocco","year":"2015","journal-title":"Respir Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1159\/000550078","article-title":"Invasive cardiopulmonary exercise testing identifies distinctive hemodynamic phenotypes in patients with interstitial lung disease and exercise intolerance.","volume":"105","author":"Balakrishnan","year":"2026","journal-title":"Respiration."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in patients with progressive pulmonary fibrosis.","volume":"392","author":"Maher","year":"2025","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis.","volume":"392","author":"Richeldi","year":"2025","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S2213-2600(20)30356-8","article-title":"Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B62","unstructured":"2026"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2502731","DOI":"10.1183\/13993003.02731-2025","article-title":"Sotatercept improves small airway disease and hyperinflation in patients with pulmonary hypertension.","volume":"67","author":"Poor","year":"2026","journal-title":"Eur Respir J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s12325-026-03508-4","article-title":"Screening for pulmonary hypertension in interstitial lung disease: preliminary results from the PHINDER study.","volume":"43","author":"Zisman","year":"2026","journal-title":"Adv Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1908302\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:10:30Z","timestamp":1791198630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1908302\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":64,"alternative-id":["10.3389\/fmed.2026.1908302"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1908302","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1908302"}}